A Hormone Decontamination Study is performed to generate documented evidence that the established decontamination controls are capable of reducing or controlling hormone residues to predefined acceptable levels. An important objective is to demonstrate that hormone dust or residues do not migrate into areas where non-hormonal products are manufactured.
What Is a Hormone Decontamination Study?
A Hormone Decontamination Study is a documented activity used to verify that contamination resulting from hormone-product manufacturing can be effectively controlled through established cleaning and decontamination measures.
The study can include:
- Hormone products and residues generated during manufacturing.
- Contaminated garments and reusable linen.
- Rejected or non-recoverable hormone materials.
- Waste generated during cleaning and decontamination.
- Drains and potentially contaminated drainage points.
- ETP systems handling contaminated wastewater.
- Containers used for contaminated linen.
- Personnel involved in collection, transportation, washing, cleaning, waste handling, and disposal.
The purpose is not merely to obtain analytical results. The complete exercise should demonstrate that the defined controls work as intended and that contaminated materials are prevented from becoming a source of uncontrolled contamination.
Related Articles
Process Validation in OSD – Types of Validation Complete GMP procedure
A guide for CSV – Computer System Validation
Complete Procedure for Compressed Air Qualification
Why Is Hormone Decontamination Study Required?
Hormone residues can be generated during manufacturing, processing, cleaning, material handling, and movement of personnel or equipment.
If these residues are not properly controlled, contamination may potentially spread through:
- Airborne dust.
- Personnel movement.
- Contaminated garments.
- Reusable linen.
- Waste containers.
- Drains.
- Wastewater.
- Cleaning equipment.
- Shared or inadequately decontaminated containers.
- Improper handling of rejected materials.
For this reason, hormone manufacturing operations require defined segregation and controlled movement of contaminated materials.
The uploaded SOP specifically requires hormone-contaminated linen and materials to remain segregated from general or non-hormone materials and requires contaminated materials to be identified at the point where they are generated.
Hormone Decontamination Study – Importance in Pharmaceutical Manufacturing
The study provides documented evidence that contamination-control measures are functioning effectively.
A properly executed study can help demonstrate:
- Containment of hormone residues
Residues remain controlled within designated areas and do not unintentionally migrate to other manufacturing areas. - Effectiveness of decontamination
The selected cleaning or washing process is capable of reducing residues to the predefined acceptance level. - Controlled handling of contaminated linen
Used garments and linen are collected, transported, washed, and released through a controlled system. - Control of wastewater
Wastewater containing hormone residues is routed through an approved treatment system rather than uncontrolled discharge. - Appropriate waste management
Non-recoverable hormone-containing materials are segregated and disposed of through approved routes. - Analytical verification
Sampling and testing provide objective evidence of the effectiveness of the process.
Responsibilities
| Department | Responsibility |
| Quality Assurance | Coordinate and execute the study, prepare the protocol, collect applicable samples, review compliance, and compile the report |
| Production | Provide operational support and ensure the approved procedure is followed in the hormone manufacturing area |
| Quality Control | Perform analysis of collected samples and document analytical results |
| Engineering | Provide technical support for drains, ETP systems, equipment, utilities, and related activities |
Important Definitions
Hormone Product
A pharmaceutical product containing an active hormone or hormone-related active pharmaceutical ingredient.
Contaminated Linen
Reusable or disposable textile material that has come into contact with a hormone product, residue, contaminated equipment, or a hormone manufacturing environment.
Decontamination
A validated or verified process intended to remove, reduce, or control contamination to an established acceptable level.
Non-Recoverable or Rejected Waste
Hormone-containing material that is not intended for further use, recovery, or processing and therefore requires an approved disposal route.
Clean Linen
Linen that has completed the approved washing or decontamination process and meets applicable release requirements.
Worst Case
A product, material, location, or condition that represents the greatest challenge to the effectiveness of the decontamination process.
ETP
Effluent Treatment Plant used for treatment of wastewater generated by the pharmaceutical facility.
General Requirements for Hormone Decontamination Study
Hormone products and contaminated materials should be handled only in designated and controlled areas according to approved manufacturing and containment procedures.
The following controls are particularly important:
- Personnel should wear the PPE specified in the applicable SOP and risk assessment.
- Hormone-contaminated materials should not be mixed with general or non-hormone materials.
- Contaminated materials should be identified immediately after generation.
- Disposable contaminated materials should be placed in closed and appropriately labelled containers or bags.
- Reusable contaminated linen should be collected in designated closed containers.
- Contaminated linen should follow an approved route to the designated washing or decontamination area.
- Activities capable of generating airborne hormone dust, including inappropriate dry cleaning practices, should be avoided.
These controls are important because effective decontamination begins with proper segregation and handling before the actual washing or cleaning step.
Risk-Based Selection of Sampling Locations during Hormone Decontamination Study
Sampling should not be based only on convenient locations.
Locations should be selected using a documented risk assessment that considers where hormone residues are most likely to contact, accumulate, or remain after manufacturing, cleaning, material handling, and personnel movement.
Examples include:
- Frequently contacted surfaces.
- Low points.
- Drains and drain traps.
- Areas where residues may accumulate.
- Linen locations that may retain contamination.
- Wastewater collection and treatment locations.
- Equipment or containers exposed to contaminated materials.
The source SOP specifically describes the sampling strategy as risk-based and focuses on locations with a reasonable potential for hormone contact or accumulation.
Sampling and Analytical Verification
Sampling is one of the most important parts of the study because visual cleanliness alone cannot demonstrate that hormone residues have been adequately removed.
QA personnel may collect swab samples from predefined locations using suitable swab devices. The samples are then submitted to QC for chemical analysis.
QC evaluates the samples for the applicable hormone residue and records the analytical results.
The sampling procedure should be clearly described in the approved protocol, including:
- Sampling location.
- Sampling method.
- Sampling area, where applicable.
- Sampling material.
- Solvent or diluent.
- Sample identification.
- Date and time.
- Analyst or sampler.
- Analytical method.
- Acceptance limit.
- Result.
- Conclusion.
Drain Decontamination
Drains can become important contamination-control points because residues and wash water may enter the drainage system.
The uploaded SOP describes a drain decontamination approach involving an initial water flush followed by a 2.0% w/v sodium hydroxide solution prepared using purified water. The solution is then introduced into the drain with sufficient contact with internal surfaces, traps, and low points. The resulting liquid is routed to the designated ETP rather than an uncontrolled outlet.
The actual concentration, quantity, contact time, and method used at a manufacturing site should always be supported by the site’s approved procedure, safety assessment, and applicable validation or verification study.
Recommended Drain Sampling Locations
Risk-based sampling may include:
- Drain trap.
- Drain low point.
- Internal drain surface.
- Final drain collection point.
These locations represent areas where residues may remain or accumulate within the drainage system.
ETP Management During Decontamination
Wastewater generated from hormone manufacturing or contaminated-linen washing should be managed through a controlled wastewater-treatment system.
The uploaded SOP describes an ETP sequence involving reaction/treatment, pH adjustment, aeration, settling, sludge removal, and final treated-water collection. It also identifies treatment chemicals and operating durations within the described process.
Because ETP operation depends on the specific facility, wastewater characteristics, treatment design, applicable environmental requirements, and validated operating conditions, the site’s approved ETP SOP should be followed rather than applying the example chemical quantities universally.
ETP Sampling Locations
Sampling locations should be selected according to the contamination risk and treatment process.
| Area | Sampling Point |
| Collection system | Collection tank |
| Low point | Tank bottom |
| Tank surface | Tank wall |
| Aeration system | Blower 1 / Blower 2 |
| Transfer system | Transfer pump |
| Piping | Low point or dead leg |
| Treatment | Treatment tank |
| Sludge | Sludge-contact area |
| Final output | Final treated effluent |
| Solid residue | Sludge |
These locations are intended to provide coverage of areas where hormone residues could potentially accumulate or pass through the treatment system.
Acceptance Criteria for the Hormone Decontamination Study
Acceptance criteria should be established before execution of the study.
They should not be selected after seeing the analytical results.
The criteria should have a scientific basis and consider:
- Applicable HBEL/PDE.
- Environmental requirements.
- Analytical capability.
- Intended use or disposition of treated effluent.
- Applicable internal specifications.
- Validated or verified analytical methods.
Decontamination of Contaminated Linen – Hormone Decontamination Study
Reusable linen used in hormone manufacturing requires particular attention because fabric can retain residues in areas that are not easily exposed to washing and rinsing.
Potential sampling locations include:
- Central area of the linen.
- Corners and edges.
- Folded or overlapping sections.
- Stitched areas.
- High-contact areas.
These locations help provide a more representative assessment of the effectiveness of the washing process.
Segregation of Hormone-Contaminated Linen
Used linen from hormone manufacturing areas should remain segregated from general linen.
The contaminated linen should be placed into a dedicated and appropriately identified container.
During internal transportation:
- The container should remain closed.
- The approved transportation route should be followed.
- Linen should not be shaken or beaten.
- Manual handling that can generate dust or aerosols should be avoided.
- The container should be cleaned after use according to the approved procedure.
The purpose of these controls is to prevent contamination from spreading during movement between the manufacturing and washing areas.
Pre-Treatment and Decontamination of Linen
The decontamination method should be selected based on the characteristics of the specific hormone.
Before implementation, the process should be supported by appropriate cleaning or decontamination studies.
If a chemical decontamination agent is used, its compatibility should be assessed with:
- The hormone residue.
- Linen material.
- Washing equipment.
- Cleaning system.
- Wastewater-treatment system.
Personnel should also avoid unnecessary contact with concentrated residues and contaminated wash water.
Washing of Reusable Linen
Only designated washing equipment should be used for hormone-contaminated linen.
The loading operation should be performed carefully to minimize dust generation.
The washing cycle should be appropriate for the characteristics of the hormone and should use the approved detergent or cleaning agent.
The source SOP describes two washing cycles followed by final rinsing with purified water. Wash and rinse water containing hormone residues should be routed through the approved wastewater system.
The exact washing parameters should be established and justified through the site’s approved procedure and supporting decontamination study rather than being assumed to apply universally to every hormone product.
Handling Non-Recoverable – Hormone Decontamination Study
Non-recoverable hormone-containing material should be separated from recoverable material.
- Rejected hormone product.
- Expired hormone product.
- Product-contaminated disposable PPE.
- Contaminated filters.
- Contaminated packaging materials.
- Disposable cleaning materials.
- Other contaminated manufacturing waste.
Such materials should be placed in suitable closed containers and properly identified. Disposal should be performed through an appropriately authorized waste-management route where required.
A waste handover or disposal record should be maintained where applicable.
Product destruction should be performed according to the approved destruction procedure and applicable legal requirements.
Decontamination of Contaminated Containers
Containers used for transporting contaminated linen can themselves become contaminated.
Therefore, they should be cleaned after each use according to the approved cleaning procedure.
The process should ensure that:
- Visible residues are removed.
- The approved cleaning agent is used.
- The container is inspected before reuse.
- Swab or rinse sampling is performed where required.
- Cleaning records are maintained.
These controls help prevent the container from becoming a secondary source of contamination.
What Happens if Decontamination Fails during Hormone Decontamination Study
A failed result should never simply be ignored or overwritten by repeating the test without investigation.
If decontamination is found to be ineffective:
- Identify the affected linen or material.
- Segregate it from released or clean material.
- Initiate the applicable deviation or investigation.
- Determine the likely cause of failure.
- Assess the potential impact.
- Determine whether repeat decontamination is scientifically justified.
- Repeat the validated process only after appropriate approval.
- Dispose of the material through the approved waste route if satisfactory decontamination cannot be achieved.
The uploaded SOP specifically requires investigation and segregation when decontamination is ineffective and allows repeat decontamination only when scientifically justified and approved.
Cleaning of the Washing and Decontamination Area
The washing area itself should be included in the contamination-control strategy.
After completion of washing:
- The designated area should be cleaned according to the approved procedure.
- Floors and surfaces should be cleaned using suitable wet-cleaning methods where appropriate.
- Dry mopping of potentially contaminated residues should be avoided.
- Cleaning equipment should be suitably identified and segregated.
- Waste generated during cleaning should follow the approved disposal procedure.
Documentation includes
A Hormone Decontamination Study should generate sufficient documentation to demonstrate what was planned, what was performed, what was tested, and how the conclusion was reached.
Typical records may include:
- Approved study protocol.
- Risk assessment.
- Product or batch details.
- Sampling plan.
- Sampling records.
- Sample identification records.
- Analytical reports.
- Raw analytical data, where applicable.
- Decontamination records.
- Linen washing records.
- ETP operating records.
- ETP sampling results.
- Waste disposal records.
- Deviation or investigation records, where applicable.
- Final study report.
- QA review and approval.
Flow Chart
A simple workflow for a Hormone Decontamination Study can be represented as:
Study Planning
↓
Risk Assessment
↓
Protocol Preparation and Approval
↓
Selection of Products/Batches
↓
Identification of Sampling Locations
↓
Execution of Decontamination/Washing Activity
↓
Collection of Samples
↓
QC Analysis
↓
Comparison with Acceptance Criteria
↓
Investigation of Any Failure
↓
Compilation of Results
↓
QA Review
↓
Final Study Conclusion
Common Mistakes in Hormone Decontamination Study
Several practical problems can reduce the value of a decontamination study.
1. Selecting Sampling Locations Without Risk Assessment
Choosing locations only because they are easy to access may fail to represent the areas with the highest contamination risk.
2. Defining Acceptance Criteria After Testing
Acceptance criteria should be established before execution rather than selected according to the results obtained.
3. Mixing Hormone and Non-Hormone Linen
Contaminated linen should remain segregated throughout collection, transportation, washing, and release.
4. Relying Only on Visual Inspection
A clean-looking surface may still contain measurable residues. Analytical verification is therefore important where required.
5. Direct Disposal of Hormone Residues
Concentrated hormone residues and solid contaminated materials should not be casually discharged into drains.
6. Reusing Contaminated Containers Without Cleaning
Transport containers can themselves become contaminated and should be cleaned after use.
FAQs Hormone Decontamination Study
What is the purpose of a Hormone Decontamination Study?
The primary purpose is to generate documented evidence that hormone residues are effectively controlled and that contamination does not unintentionally spread to non-hormone manufacturing areas.
How many batches should be included in the study?
The uploaded SOP specifies three consecutive products or batches for the described exercise. The actual number should be based on the approved study protocol and applicable site requirements.
Why is risk-based sampling important?
Risk-based sampling helps identify locations where hormone residues are most likely to accumulate or remain after manufacturing, cleaning, transportation, or washing.
What locations can be sampled after linen washing?
Potential locations include the center, corners and edges, folded areas, stitched portions, and high-contact areas of the linen.
References
- Approved site SOP for hormone decontamination study and associated contamination-control activities.
- Applicable site cleaning/decontamination procedures.
- Applicable site ETP operation and monitoring procedure.